Autopsy report · NCT00971074
Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy
Cause of deathSlow enrollment
“Patients did not meet inclusion criteria.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Grant Jones
- Sponsor type
- University, hospital or other
- Conditions
- Arthralgia
- Interventions
- Hylan G-F 20; Sham Injection
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Late Biomarkers in Adult Survivors After Out-of-hospital Cardiac Arrest
“For logistical reasons, no patients were included before the main trial completed inclusion.” - Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
“No patient corresponding to inclusion criteria couldn't be enrolled in the study” - Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
“No eligible patients were enrolled.” - Bioavailability of Voriconazole
“no eligible patients; study stopped without inclusion” - Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
“No eligible patient was enrolled.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.